razoxane has been researched along with Cells, Neoplasm Circulating in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cuman, R; Giraldi, T; Lassiani, L; Nisi, C; Sava, G | 1 |
| Garattini, S; Spreafico, F | 1 |
1 review(s) available for razoxane and Cells, Neoplasm Circulating
| Article | Year |
|---|---|
Selective antimetastatic treatment--current status and future prospects.
Topics: Animals; Carcinoma, Ehrlich Tumor; Cyclophosphamide; Drug Evaluation, Preclinical; Humans; Immunotherapy; Leukemia L1210; Lung Neoplasms; Lymphatic Metastasis; Mice; Mice, Inbred Strains; Models, Biological; Neoplasm Metastasis; Neoplasm Seeding; Neoplasm Transplantation; Neoplasms, Experimental; Neoplastic Cells, Circulating; Polyethylene Glycols; Rats; Razoxane; Semustine | 1974 |
1 other study(ies) available for razoxane and Cells, Neoplasm Circulating
| Article | Year |
|---|---|
Selectivity of the antimetastatic and cytotoxic effects of 1-p-(3,3-dimethyl-1-triazeno)benzoic acid potassium salt (+/-)-1,2-di(3,5-dioxopiperazin-1-yl)propane, and cyclophosphamide in mice bearing Lewis lung carcinoma.
Topics: Animals; Antineoplastic Agents; Cyclophosphamide; Lung Neoplasms; Mice; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms, Experimental; Neoplastic Cells, Circulating; Piperazines; Razoxane; Thymidine; Time Factors; Triazenes | 1981 |